Home
Conditions
Recurrent Grade 3 Follicular Lymphoma

Clinical trial condition

Recurrent Grade 3 Follicular Lymphoma

Explore clinical trials studying Recurrent Grade 3 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

99 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Grade 3 Follicular Lymphoma trial results

Active, not recruiting

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

NCT01849263

Conditions: Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States

View all 13 locations

View Trial Details

Active, not recruiting

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

NCT01318317

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma

NCT01479842

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +29 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Active, not recruiting

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

NCT01815749

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

NCT04205409

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +46 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

NCT02332980

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +48 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

NCT02568553

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

View all 24 locations

View Trial Details

Completed

Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma

NCT01995669

Conditions: Chronic Disease, Disease Attributes, Grade 3a Follicular Lymphoma, +28 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT03583424

Conditions: Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Immune System Diseases, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recurrent Grade 3 Follicular Lymphoma

Recurrent Grade 3 Follicular Lymphoma trial results

Related conditions